Thomson Reuters to switch its U.S. stock listing to Nasdaq

Thomson Reuters to List U.S. Shares on Nasdaq

Thomson Reuters, a leading content and technology company, has announced its decision to transfer its U.S. stock listing from the New York Stock Exchange (NYSE) to the Nasdaq. This move is expected to become effective on or around February 25.

According to the company, the transition will not affect its shares listed on the Toronto Stock Exchange (TSX) in Canada. The common stock will retain the ticker symbol "TRI" on both exchanges.

This strategic move underscores Thomson Reuters' ongoing commitment to optimizing its financial operations and aligning with industry best practices. The company believes that the Nasdaq provides an ideal platform for growth and value creation.

Thomson Reuters serves a global audience with its extensive range of products and services, including financial data, news, and professional tools. The company's decision to list on the Nasdaq is expected to enhance its visibility and liquidity in the U.S. equity market.

The Economy Is Slowing Down, and the Market Is Ignoring It

The market is trading near record highs, but concerning economic trends suggest a slowdown. Economic growth is slowing, the consumer is softening, housing is weak, and government spending is slowing. The Fed's pause in rate cuts, in a slowing economy, is de facto raising rates. Long-term rates and stocks are expected to fall.

Published on: February 25, 2025, 05:03 PM UTC

CVS Cuts Bonuses Amid Medicare Woes

CVS Health has cut bonuses for some employees due to low profit levels in 2024, driven by higher costs in Medicare plans and increased healthcare expenses.

Published on: February 22, 2025, 12:00 AM UTC

Select Medical Shares Plunge on Disappointing Q4 Results

Select Medical (SEM) shares fell 14.1% after disappointing Q4 results. Despite the drop, SEM's stock has only had 5 moves greater than 5% in the past year, making this a significant market reaction. Get our full analysis report for free.

Published on: February 21, 2025, 09:01 PM UTC

Akamai Stock Falls 20% on Weak Earnings; Is It a Buy?

Akamai (AKAM) stock dropped 20.3% after reporting weak Q4 results, with revenue guidance signaling a slowdown in demand. Revenue grew only 3% YoY, overshadowed by an 18% drop in delivery revenue. Adjusted operating profits and earnings beat expectations, but the full-year outlook implies only 2.7% revenue growth.

Published on: February 21, 2025, 09:00 PM UTC

Celsius (CELH) Stock Trades Up 39% on Strong Q4 Results and Alani Nu Acquisition

Shares of energy drink company Celsius (NASDAQ:CELH) jumped 39% after strong Q4 results and acquisition announcement. Analysts provide positive updates, suggesting improving demand and strong positioning in the competitive energy drink market.

Published on: February 21, 2025, 09:00 PM UTC

Thomson Reuters to switch its U.S. stock listing to Nasdaq

Related Posts

The Economy Is Slowing Down, and the Market Is Ignoring It

CVS Cuts Bonuses Amid Medicare Woes

Select Medical Shares Plunge on Disappointing Q4 Results

Akamai Stock Falls 20% on Weak Earnings; Is It a Buy?

Celsius (CELH) Stock Trades Up 39% on Strong Q4 Results and Alani Nu Acquisition

Categories

Tags

Hot Posts